Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Sullivan, V. Ghushchyan (2006)
Preference-Based EQ-5D Index Scores for Chronic Conditions in the United StatesMedical Decision Making, 26
V. Grann, K. Panageas, W. Whang, K. Antman, A. Neugut (1998)
Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 3
André Fortin, M. Larochelle, Jacques Laverdière, Sophie Lavertu, Daniel Tremblay (1999)
Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 1
A. Taghian, K. Kozak, A. Katz, J. Adams, Hsiao-Ming Lu, S. Powell, T. Delaney (2006)
Accelerated partial breast irradiation using proton beams: Initial dosimetric experience.International journal of radiation oncology, biology, physics, 65 5
A. Santos, L. Marcu, Chia Wong, E. Bezak (2016)
Risk estimation of second primary cancers after breast radiotherapyActa Oncologica, 55
Paiman Ghafoori, L. Marks, Ž. Vujašković, C. Kelsey (2008)
Radiation-induced lung injury. Assessment, management, and prevention.Oncology, 22 1
J. Lundkvist, M. Ekman, S. Ericsson, U. Isacsson, B. Jönsson, B. Glimelius (2005)
Economic evaluation of proton radiation therapy in the treatment of breast cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 75 2
( Cameron D , Piccart‐Gebhart MJ , Gelber RD , et al. 11 years' follow‐up of trastuzumab after adjuvant chemotherapy in HER2‐positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial. Lancet 2017; 389: 1195–205.28215665)
Cameron D , Piccart‐Gebhart MJ , Gelber RD , et al. 11 years' follow‐up of trastuzumab after adjuvant chemotherapy in HER2‐positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial. Lancet 2017; 389: 1195–205.28215665Cameron D , Piccart‐Gebhart MJ , Gelber RD , et al. 11 years' follow‐up of trastuzumab after adjuvant chemotherapy in HER2‐positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial. Lancet 2017; 389: 1195–205.28215665, Cameron D , Piccart‐Gebhart MJ , Gelber RD , et al. 11 years' follow‐up of trastuzumab after adjuvant chemotherapy in HER2‐positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial. Lancet 2017; 389: 1195–205.28215665
DC Weber, C Ares, AJ Lomax, JM Kurtz (2006)
Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview, 1
(2018)
A retrospective dosimetric comparison of proton and X-ray therapy with deep inspiration breath hold for left-sided early stage breast cancer: a pilot study
D. Cameron, M. Piccart-Gebhart, R. Gelber, M. Procter, A. Goldhirsch, E. Azambuja, G. Castro, M. Untch, I. Smith, L. Gianni, J. Baselga, N. Al-Sakaff, S. Lauer, E. McFadden, B. Leyland-Jones, R. Bell, M. Dowsett, C. Jackisch (2017)
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trialThe Lancet, 389
( Cunningham L . A retrospective dosimetric comparison of proton and X‐ray therapy with deep inspiration breath hold for left‐sided early stage breast cancer: a pilot study. University of South Australia, Adelaide, 2018.)
Cunningham L . A retrospective dosimetric comparison of proton and X‐ray therapy with deep inspiration breath hold for left‐sided early stage breast cancer: a pilot study. University of South Australia, Adelaide, 2018.Cunningham L . A retrospective dosimetric comparison of proton and X‐ray therapy with deep inspiration breath hold for left‐sided early stage breast cancer: a pilot study. University of South Australia, Adelaide, 2018., Cunningham L . A retrospective dosimetric comparison of proton and X‐ray therapy with deep inspiration breath hold for left‐sided early stage breast cancer: a pilot study. University of South Australia, Adelaide, 2018.
( Bijman RG , Breedveld S , Arts T , et al. Impact of model and dose uncertainty on model‐based selection of oropharyngeal cancer patients for proton therapy. Acta Oncol 2017; 56: 1444–50.28828923)
Bijman RG , Breedveld S , Arts T , et al. Impact of model and dose uncertainty on model‐based selection of oropharyngeal cancer patients for proton therapy. Acta Oncol 2017; 56: 1444–50.28828923Bijman RG , Breedveld S , Arts T , et al. Impact of model and dose uncertainty on model‐based selection of oropharyngeal cancer patients for proton therapy. Acta Oncol 2017; 56: 1444–50.28828923, Bijman RG , Breedveld S , Arts T , et al. Impact of model and dose uncertainty on model‐based selection of oropharyngeal cancer patients for proton therapy. Acta Oncol 2017; 56: 1444–50.28828923
( Grann VR , Panageas KS , Whang W , Antman KH , Neugut AI . Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1‐positive or BRCA2‐positive patients. J Clin Oncol 1998; 16: 979–85.9508180)
Grann VR , Panageas KS , Whang W , Antman KH , Neugut AI . Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1‐positive or BRCA2‐positive patients. J Clin Oncol 1998; 16: 979–85.9508180Grann VR , Panageas KS , Whang W , Antman KH , Neugut AI . Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1‐positive or BRCA2‐positive patients. J Clin Oncol 1998; 16: 979–85.9508180, Grann VR , Panageas KS , Whang W , Antman KH , Neugut AI . Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1‐positive or BRCA2‐positive patients. J Clin Oncol 1998; 16: 979–85.9508180
U. Schneider, Marcin Sumila, Judith Robotka (2011)
Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapyTheoretical Biology & Medical Modelling, 8
B. Burton (1956)
From AustraliaPastoral Psychology, 7
( Lin LL , Vennarini S , Dimofte A , et al. Proton beam versus photon beam dose to the heart and left anterior descending artery for left‐sided breast cancer. Acta Oncol 2015; 54: 1032–9.25789715)
Lin LL , Vennarini S , Dimofte A , et al. Proton beam versus photon beam dose to the heart and left anterior descending artery for left‐sided breast cancer. Acta Oncol 2015; 54: 1032–9.25789715Lin LL , Vennarini S , Dimofte A , et al. Proton beam versus photon beam dose to the heart and left anterior descending artery for left‐sided breast cancer. Acta Oncol 2015; 54: 1032–9.25789715, Lin LL , Vennarini S , Dimofte A , et al. Proton beam versus photon beam dose to the heart and left anterior descending artery for left‐sided breast cancer. Acta Oncol 2015; 54: 1032–9.25789715
A. Austin, Michael Douglass, G. Nguyen, S. Penfold (2017)
A radiobiological Markov simulation tool for aiding decision making in proton therapy referral.Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics, 44
V. Bruzzaniti, A. Abate, P. Pinnaró, M. D’Andrea, E. Infusino, V. Landoni, A. Soriani, C. Giordano, Anna Ferraro, L. Strigari (2013)
Dosimetric and clinical advantages of deep inspiration breath-hold (DIBH) during radiotherapy of breast cancerJournal of Experimental & Clinical Cancer Research : CR, 32
Australian facts
( Sullivan PW , Ghushchyan V . Preference‐based EQ‐5D index scores for chronic conditions in the United States. Med Decis Making 2006; 26: 410–20.16855129)
Sullivan PW , Ghushchyan V . Preference‐based EQ‐5D index scores for chronic conditions in the United States. Med Decis Making 2006; 26: 410–20.16855129Sullivan PW , Ghushchyan V . Preference‐based EQ‐5D index scores for chronic conditions in the United States. Med Decis Making 2006; 26: 410–20.16855129, Sullivan PW , Ghushchyan V . Preference‐based EQ‐5D index scores for chronic conditions in the United States. Med Decis Making 2006; 26: 410–20.16855129
A. Lomax, L. Cella, D. Weber, J. Kurtz, R. Miralbell (2003)
Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes.International journal of radiation oncology, biology, physics, 55 3
( Santos AM , Marcu LG , Wong CM , Bezak E . Risk estimation of second primary cancers after breast radiotherapy. Acta Oncol 2016; 55: 1331–7.27379458)
Santos AM , Marcu LG , Wong CM , Bezak E . Risk estimation of second primary cancers after breast radiotherapy. Acta Oncol 2016; 55: 1331–7.27379458Santos AM , Marcu LG , Wong CM , Bezak E . Risk estimation of second primary cancers after breast radiotherapy. Acta Oncol 2016; 55: 1331–7.27379458, Santos AM , Marcu LG , Wong CM , Bezak E . Risk estimation of second primary cancers after breast radiotherapy. Acta Oncol 2016; 55: 1331–7.27379458
( Ghafoori P , Marks LB , Vujaskovic Z , Kelsey CR . Radiation‐induced lung injury. Assessment, management, and prevention. Oncology (Williston Park) 2008; 22: 37–47.18251282)
Ghafoori P , Marks LB , Vujaskovic Z , Kelsey CR . Radiation‐induced lung injury. Assessment, management, and prevention. Oncology (Williston Park) 2008; 22: 37–47.18251282Ghafoori P , Marks LB , Vujaskovic Z , Kelsey CR . Radiation‐induced lung injury. Assessment, management, and prevention. Oncology (Williston Park) 2008; 22: 37–47.18251282, Ghafoori P , Marks LB , Vujaskovic Z , Kelsey CR . Radiation‐induced lung injury. Assessment, management, and prevention. Oncology (Williston Park) 2008; 22: 37–47.18251282
J. Lundkvist, M. Ekman, S. Ericsson, B. Jönsson, B. Glimelius (2005)
Cost‐effectiveness of proton radiation in the treatment of childhood medulloblastomaCancer, 103
( Taghian AG , Kozak KR , Katz A , et al. Accelerated partial breast irradiation using proton beams: Initial dosimetric experience. Int J Radiat Oncol Biol Phys 2006; 65: 1404–10.16730137)
Taghian AG , Kozak KR , Katz A , et al. Accelerated partial breast irradiation using proton beams: Initial dosimetric experience. Int J Radiat Oncol Biol Phys 2006; 65: 1404–10.16730137Taghian AG , Kozak KR , Katz A , et al. Accelerated partial breast irradiation using proton beams: Initial dosimetric experience. Int J Radiat Oncol Biol Phys 2006; 65: 1404–10.16730137, Taghian AG , Kozak KR , Katz A , et al. Accelerated partial breast irradiation using proton beams: Initial dosimetric experience. Int J Radiat Oncol Biol Phys 2006; 65: 1404–10.16730137
( AIHW . Cardiovascular disease: Australian facts, Available from https://www.aihw.gov.au/reports/heart‐stroke‐vascular‐disease/cardiovascular‐disease‐australian‐facts‐2011/contents/table‐of‐contents; Accessed 1‐11‐2011. Cardiovascular disease series 2011;53.)
AIHW . Cardiovascular disease: Australian facts, Available from https://www.aihw.gov.au/reports/heart‐stroke‐vascular‐disease/cardiovascular‐disease‐australian‐facts‐2011/contents/table‐of‐contents; Accessed 1‐11‐2011. Cardiovascular disease series 2011;53.AIHW . Cardiovascular disease: Australian facts, Available from https://www.aihw.gov.au/reports/heart‐stroke‐vascular‐disease/cardiovascular‐disease‐australian‐facts‐2011/contents/table‐of‐contents; Accessed 1‐11‐2011. Cardiovascular disease series 2011;53., AIHW . Cardiovascular disease: Australian facts, Available from https://www.aihw.gov.au/reports/heart‐stroke‐vascular‐disease/cardiovascular‐disease‐australian‐facts‐2011/contents/table‐of‐contents; Accessed 1‐11‐2011. Cardiovascular disease series 2011;53.
( Schneider U , Sumila M , Robotka J . Site‐specific dose‐response relationships for cancer induction from the combined Japanese A‐bomb and Hodgkin cohorts for doses relevant to radiotherapy. Theor Biol Med Model 2011; 8: 27.21791103)
Schneider U , Sumila M , Robotka J . Site‐specific dose‐response relationships for cancer induction from the combined Japanese A‐bomb and Hodgkin cohorts for doses relevant to radiotherapy. Theor Biol Med Model 2011; 8: 27.21791103Schneider U , Sumila M , Robotka J . Site‐specific dose‐response relationships for cancer induction from the combined Japanese A‐bomb and Hodgkin cohorts for doses relevant to radiotherapy. Theor Biol Med Model 2011; 8: 27.21791103, Schneider U , Sumila M , Robotka J . Site‐specific dose‐response relationships for cancer induction from the combined Japanese A‐bomb and Hodgkin cohorts for doses relevant to radiotherapy. Theor Biol Med Model 2011; 8: 27.21791103
( Weber DC , Ares C , Lomax AJ , Kurtz JM . Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview. Radiat Oncol 2006; 1: 22.16857055)
Weber DC , Ares C , Lomax AJ , Kurtz JM . Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview. Radiat Oncol 2006; 1: 22.16857055Weber DC , Ares C , Lomax AJ , Kurtz JM . Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview. Radiat Oncol 2006; 1: 22.16857055, Weber DC , Ares C , Lomax AJ , Kurtz JM . Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview. Radiat Oncol 2006; 1: 22.16857055
( Mailhot Vega RB , Ishaq O , Raldow A , et al. Establishing cost‐effective allocation of proton therapy for breast irradiation. Int J Radiat Oncol Biol Phys 2016; 95: 11–8.27084617)
Mailhot Vega RB , Ishaq O , Raldow A , et al. Establishing cost‐effective allocation of proton therapy for breast irradiation. Int J Radiat Oncol Biol Phys 2016; 95: 11–8.27084617Mailhot Vega RB , Ishaq O , Raldow A , et al. Establishing cost‐effective allocation of proton therapy for breast irradiation. Int J Radiat Oncol Biol Phys 2016; 95: 11–8.27084617, Mailhot Vega RB , Ishaq O , Raldow A , et al. Establishing cost‐effective allocation of proton therapy for breast irradiation. Int J Radiat Oncol Biol Phys 2016; 95: 11–8.27084617
( ABS . Life Tables, States, Territories and Australia, 2013–2015. 2016.)
ABS . Life Tables, States, Territories and Australia, 2013–2015. 2016.ABS . Life Tables, States, Territories and Australia, 2013–2015. 2016., ABS . Life Tables, States, Territories and Australia, 2013–2015. 2016.
Lilie Lin, S. Vennarini, A. Dimofte, D. Ravanelli, Katie Shillington, S. Batra, Z. Tochner, S. Both, G. Freedman (2013)
Proton beam versus photon beam dose to the heart and left anterior descending artery for left-sided breast cancerActa Oncologica, 54
M. Oken, R. Creech, D. Tormey, J. Horton, T. Davis, E. McFadden, P. Carbone (1982)
Toxicity and response criteria of the Eastern Cooperative Oncology GroupAMERICAN JOURNAL OF CLINICAL ONCOLOGY, 5
( Fortin A , Larochelle M , Laverdière J , Lavertu S , Tremblay D . Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 1999; 17: 101.10458223)
Fortin A , Larochelle M , Laverdière J , Lavertu S , Tremblay D . Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 1999; 17: 101.10458223Fortin A , Larochelle M , Laverdière J , Lavertu S , Tremblay D . Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 1999; 17: 101.10458223, Fortin A , Larochelle M , Laverdière J , Lavertu S , Tremblay D . Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 1999; 17: 101.10458223
( Oken MM , Creech RH , Tormey DC , et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 1982; 5: 649–55.7165009)
Oken MM , Creech RH , Tormey DC , et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 1982; 5: 649–55.7165009Oken MM , Creech RH , Tormey DC , et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 1982; 5: 649–55.7165009, Oken MM , Creech RH , Tormey DC , et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 1982; 5: 649–55.7165009
(2012)
Methods for the development of NICE public health guidance (third edition) -incorporating health economics
( Lomax AJ , Cella L , Weber D , Kurtz JM , Miralbell R . Potential role of intensity‐modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys 2003; 55: 785–92.12573766)
Lomax AJ , Cella L , Weber D , Kurtz JM , Miralbell R . Potential role of intensity‐modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys 2003; 55: 785–92.12573766Lomax AJ , Cella L , Weber D , Kurtz JM , Miralbell R . Potential role of intensity‐modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys 2003; 55: 785–92.12573766, Lomax AJ , Cella L , Weber D , Kurtz JM , Miralbell R . Potential role of intensity‐modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys 2003; 55: 785–92.12573766
(2011)
Accessed 1-11-2011. Cardiovascular disease series
R. Bijman, S. Breedveld, T. Arts, E. Astreinidou, M. Jong, P. Granton, S. Petit, M. Hoogeman (2017)
Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapyActa Oncologica, 56
( Austin AM , Douglass MJ , Nguyen GT , Penfold SN . A radiobiological Markov simulation tool for aiding decision making in proton therapy referral. Physica Med 2017; 44: 72–82.)
Austin AM , Douglass MJ , Nguyen GT , Penfold SN . A radiobiological Markov simulation tool for aiding decision making in proton therapy referral. Physica Med 2017; 44: 72–82.Austin AM , Douglass MJ , Nguyen GT , Penfold SN . A radiobiological Markov simulation tool for aiding decision making in proton therapy referral. Physica Med 2017; 44: 72–82., Austin AM , Douglass MJ , Nguyen GT , Penfold SN . A radiobiological Markov simulation tool for aiding decision making in proton therapy referral. Physica Med 2017; 44: 72–82.
(2006)
Radiation Oncology BioMed Central Review Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview
( Lundkvist J , Ekman M , Ericsson SR , Jönsson B , Glimelius B . Cost‐effectiveness of proton radiation in the treatment of childhood medulloblastoma. Cancer 2005; 103: 793–801.15637691)
Lundkvist J , Ekman M , Ericsson SR , Jönsson B , Glimelius B . Cost‐effectiveness of proton radiation in the treatment of childhood medulloblastoma. Cancer 2005; 103: 793–801.15637691Lundkvist J , Ekman M , Ericsson SR , Jönsson B , Glimelius B . Cost‐effectiveness of proton radiation in the treatment of childhood medulloblastoma. Cancer 2005; 103: 793–801.15637691, Lundkvist J , Ekman M , Ericsson SR , Jönsson B , Glimelius B . Cost‐effectiveness of proton radiation in the treatment of childhood medulloblastoma. Cancer 2005; 103: 793–801.15637691
( Bruzzaniti V , Abate A , Pinnarò P , et al. Dosimetric and clinical advantages of deep inspiration breath‐hold (DIBH) during radiotherapy of breast cancer. J Exp Clin Cancer Res 2013; 32: 88.24423396)
Bruzzaniti V , Abate A , Pinnarò P , et al. Dosimetric and clinical advantages of deep inspiration breath‐hold (DIBH) during radiotherapy of breast cancer. J Exp Clin Cancer Res 2013; 32: 88.24423396Bruzzaniti V , Abate A , Pinnarò P , et al. Dosimetric and clinical advantages of deep inspiration breath‐hold (DIBH) during radiotherapy of breast cancer. J Exp Clin Cancer Res 2013; 32: 88.24423396, Bruzzaniti V , Abate A , Pinnarò P , et al. Dosimetric and clinical advantages of deep inspiration breath‐hold (DIBH) during radiotherapy of breast cancer. J Exp Clin Cancer Res 2013; 32: 88.24423396
R. Vega, O. Ishaq, A. Raldow, C. Perez, R. Jimenez, M. Scherrer-Crosbie, M. Bussière, A. Taghian, D. Sher, S. MacDonald (2016)
Establishing Cost-Effective Allocation of Proton Therapy for Breast Irradiation.International journal of radiation oncology, biology, physics, 95 1
( NICE . Methods for the development of NICE public health guidance (third edition) ‐ incorporating health economics. 2012.)
NICE . Methods for the development of NICE public health guidance (third edition) ‐ incorporating health economics. 2012.NICE . Methods for the development of NICE public health guidance (third edition) ‐ incorporating health economics. 2012., NICE . Methods for the development of NICE public health guidance (third edition) ‐ incorporating health economics. 2012.
Journal of Medical Radiation Sciences – Wiley
Published: Mar 1, 2021
Keywords: ; ; ; ;
You can share this free article with as many people as you like with the url below! We hope you enjoy this feature!
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.